MedaPhase Announces New Research Study Opportunities
We are the number one dermatology research center in the Atlanta area.
Since 1998, MedaPhase has conducted numerous research studies, and has played a major role in the development of some of the most important and innovative dermatology drugs including Protopic, Elidel, Enbrel, Humira, and Stelara.
Dr. Mark Ling, who previously directed the clinical research program at Emory University School of Medicine in Atlanta, established MedaPhase in 1998. Dr. Ling founded MedaPhase with a mission to bring university-quality clinical dermatology research to the south metro Atlanta area where no such opportunities previously existed. It is Dr. Ling’s belief that clinical research provides a unique opportunity to advance the frontiers of dermatology therapy.
MedaPhase is located with Avail Dermatology in a state-of-the-art facility, which opened in 2005. It is easily accessible from anywhere in the metro Atlanta area, as well as the surrounding communities of LaGrange, Columbus, and Covington.
Participating in a Clinical Research study may give participants an opportunity to try an investigational medication, and the information collected from the study may help other people in the future.
We are recruiting for the following studies
- Actinic Keratosis
- Psoriatic Arthritis
For more information on these studies, visit our website at www.healthyskinresearch.com